SE442636B - N-((4-(3-substituerad pyridyl)piperazino)butyl)azaspirodekandioner, forfarande for deras framstellning och farmaceutisk komposition derav - Google Patents

N-((4-(3-substituerad pyridyl)piperazino)butyl)azaspirodekandioner, forfarande for deras framstellning och farmaceutisk komposition derav

Info

Publication number
SE442636B
SE442636B SE8105341A SE8105341A SE442636B SE 442636 B SE442636 B SE 442636B SE 8105341 A SE8105341 A SE 8105341A SE 8105341 A SE8105341 A SE 8105341A SE 442636 B SE442636 B SE 442636B
Authority
SE
Sweden
Prior art keywords
compound
acid addition
butyl
pharmaceutically acceptable
methyl
Prior art date
Application number
SE8105341A
Other languages
English (en)
Swedish (sv)
Other versions
SE8105341L (sv
Inventor
Jr D L Temple
J P Yevich
Jr W G Lobeck
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8105341L publication Critical patent/SE8105341L/
Publication of SE442636B publication Critical patent/SE442636B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
SE8105341A 1980-09-08 1981-09-08 N-((4-(3-substituerad pyridyl)piperazino)butyl)azaspirodekandioner, forfarande for deras framstellning och farmaceutisk komposition derav SE442636B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/184,677 US4305944A (en) 1980-09-08 1980-09-08 N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones

Publications (2)

Publication Number Publication Date
SE8105341L SE8105341L (sv) 1982-03-09
SE442636B true SE442636B (sv) 1986-01-20

Family

ID=22677905

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8105341A SE442636B (sv) 1980-09-08 1981-09-08 N-((4-(3-substituerad pyridyl)piperazino)butyl)azaspirodekandioner, forfarande for deras framstellning och farmaceutisk komposition derav

Country Status (23)

Country Link
US (1) US4305944A (el)
JP (1) JPS5780381A (el)
AT (1) AT378192B (el)
AU (1) AU525584B2 (el)
BE (1) BE890265A (el)
CA (1) CA1196333A (el)
CH (1) CH649084A5 (el)
CY (1) CY1369A (el)
DE (1) DE3135523A1 (el)
DK (1) DK154647C (el)
FI (1) FI70580C (el)
FR (1) FR2489823A1 (el)
GB (1) GB2083474B (el)
GR (1) GR75756B (el)
HK (1) HK4388A (el)
IE (1) IE51548B1 (el)
KE (1) KE3721A (el)
LU (1) LU83616A1 (el)
NL (1) NL8104144A (el)
SE (1) SE442636B (el)
SG (1) SG29987G (el)
YU (2) YU42423B (el)
ZA (1) ZA816214B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320131A (en) * 1981-03-16 1982-03-16 Mead Johnson & Company N-[(4-Phenyl-1,2,3,6-tetrahydropyridin-1-yl)alkylene]azaspiroalkanediones and N-[(4-hydroxy-4-phenylpiperidin-1-yl)alkylene]azaspiroalkanediones
US4507303A (en) * 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
AT387773B (de) * 1983-09-12 1989-03-10 Bristol Myers Co Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4656280A (en) * 1984-03-07 1987-04-07 E. I. Du Pont De Nemours And Company Radioiodinated dopamine receptor ligand
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4812567A (en) * 1985-10-16 1989-03-14 American Home Products Corporation Polycyclic spiroimides with psychotropic activity
US4748240A (en) * 1987-04-03 1988-05-31 American Home Products Corporation Psychotropic bicyclic imides
US4797488A (en) * 1987-04-03 1989-01-10 American Home Products Corporation Psychotropic polycyclic imides
HU212301B (en) * 1989-04-28 1996-05-28 Alkaloida Vegyeszeti Gyar Process for producing buspirone
US5162321A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie 1-naphthyl piperazines useful as 5-HT1A receptor ligands
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method

Also Published As

Publication number Publication date
SG29987G (en) 1987-07-17
SE8105341L (sv) 1982-03-09
ATA388181A (de) 1984-11-15
BE890265A (fr) 1982-03-08
FI812736L (fi) 1982-03-09
YU213783A (en) 1984-02-29
IE812069L (en) 1982-03-08
HK4388A (en) 1988-01-29
NL8104144A (nl) 1982-04-01
DE3135523A1 (de) 1982-06-16
CA1196333A (en) 1985-11-05
YU42423B (en) 1988-08-31
YU213881A (en) 1984-02-29
CY1369A (en) 1987-08-07
DK154647B (da) 1988-12-05
GB2083474B (en) 1984-05-31
GB2083474A (en) 1982-03-24
CH649084A5 (de) 1985-04-30
FI70580B (fi) 1986-06-06
IE51548B1 (en) 1987-01-07
JPS5780381A (en) 1982-05-19
DE3135523C2 (el) 1990-06-07
US4305944A (en) 1981-12-15
AT378192B (de) 1985-06-25
GR75756B (el) 1984-08-02
AU525584B2 (en) 1982-11-11
FR2489823B1 (el) 1985-01-11
DK154647C (da) 1989-05-08
ZA816214B (en) 1982-09-29
KE3721A (en) 1987-04-30
FR2489823A1 (fr) 1982-03-12
AU7502481A (en) 1982-03-18
LU83616A1 (fr) 1982-04-14
JPH0134226B2 (el) 1989-07-18
DK395081A (da) 1982-03-09
FI70580C (fi) 1986-09-24

Similar Documents

Publication Publication Date Title
DE60316468T2 (de) Pyrimidine verbindungen
CA2832504C (en) Compounds for inhibiting cell proliferation in egfr-driven cancers
SE442636B (sv) N-((4-(3-substituerad pyridyl)piperazino)butyl)azaspirodekandioner, forfarande for deras framstellning och farmaceutisk komposition derav
JPH0577669B2 (el)
JPS58118582A (ja) ２−〔４−〔（４，４−ジアルキル−２，６−ピペリジンジオン−１−イル）ブチル〕−１−ピペラジニル〕ピリミジン
EP1029861A1 (en) Benzisothiazol-piperazinyl derivative and its use as neuroleptic
SI9520080A (sl) Substituirane pirimidinske spojine in njihova uporaba
JP2021535207A (ja) 甲状腺ホルモン受容体ベータアゴニスト化合物
JPH01249769A (ja) 向精神性ヘテロビシクロアルキルピペラジン誘導体
IL97424A (en) Use of guanidine for the preparation of a medicinal product with anti-neuropfed Y activity
FI70708B (fi) Foerfarande foer framstaellning av nya farmaceutiskt anvaendbara 2-imidazolin-1-yl-urinaemne- och -amidofoereningar
CN111518104B (zh) 一种含硫脲嘧啶的1,2,4-三氮唑并[1,5-a]嘧啶类化合物及其制备方法和应用
SE466310B (sv) Antipsykotiska cykliska imidderivat av 2-(4-butylpiperazin-1-yl)pyridiner, farmaceutiska kompositioner innehaallande naemnda derivat samt foerfaranden foer framstaellning daerav
JPS58128384A (ja) ベンゾジオキシン化合物、その製造方法、および精神作用障害治療用医薬組成物
JP2001501949A (ja) 中枢神経系疾患を処置することに有用な５―ヘテロ原子を含有するアルキル置換された―３―オキソ―ピリド（１，２―ａ）ベンゾイミダゾール―４―カルボキサミド誘導体
JPH039912B2 (el)
SE462163B (sv) 8-/4-/4-(1-oxo-1,2-bensisotiazol-3-yl)-1-piperazinyl/butyl/-8-azaspiro/4,5/dekan-7,9-dion, farmaceutisk beredning innehaallande naemnda foerening samt foerfarande foer framstaellning daerav
US10407406B2 (en) 2-halo-5-alkynyl-pyridyl nicotinic ligands
HU190936B (en) Process for producing 2-amino-1,2,4-triazolo-/1,5-c/ pyrimidine derivatives substituted at the 5 position
JPH0319233B2 (el)
FI84348C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrimidintrionderivat.
US4581357A (en) Antipsychotic 5-fluoro-pyrimidin-2-yl piperazine compound
SE441745B (sv) Pyridylaminotriazolderivat och famaceutisk beredning innehallande dessa
KR880001375B1 (ko) 항우울증 치료제인 2-펜옥시알킬-1,2,4-트리아졸-3-온 및 그의 제조방법
WO2024077057A1 (en) Phenyl oxy amide kinase inhibitors

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8105341-5

Effective date: 19920408

Format of ref document f/p: F